[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Imagenebio Inc (IMA)

Imagenebio Inc (IMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Imagenebio Inc 12526 HIGH BLUFF DRIVE SUITE 345 SAN DIEGO CA 92130 USA

www.inmagenebio.com Employees: 15 P: 858-345-6265

Sector:

Medical

Description:

Inmagene Biopharmaceuticals is a clinical stage biotechnology company dedicated to developing disease-modifying treatments for immunological/autoimmune and inflammatory diseases. The company's lead asset includes IMG-007, a nondepleting anti-OX40 monoclonal antibody. Inmagene Biopharmaceuticals, formerly known as Ikena Oncology Inc., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 56,360
Enterprise Value, $K -38,170
Shares Outstanding, K 10,654
Float, K 10,021
% Float 94.06%
Short Interest, K 587
Short Float 5.51%
Days to Cover 1.00
Short Volume Ratio 0.22
% of Insider Shareholders 5.94%
% of Institutional Shareholders 75.00%

Financials:

Annual Sales, $ 800 K
Annual Net Income, $ -45,350 K
Last Quarter Sales, $ 800 K
Last Quarter Net Income, $ -9,180 K
EBIT, $ -50,990 K
EBITDA, $ -50,030 K

Growth:

1-Year Return -59.18%
3-Year Return -93.70%
5-Year Return -97.60%
5-Year Revenue Growth -91.29%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.91 on 11/12/25
Next Earnings Date 07/23/26
Earnings Per Share ttm -5.79
EPS Growth vs. Prev Year 56.04%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 07/28/25

IMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.53%
Return-on-Assets % -32.28%
Profit Margin % -5,668.75%
Debt/Equity 0.00
Price/Sales 78.71
Price/Cash Flow N/A
Price/Book 0.50
Book Value/Share 11.91
Interest Coverage -1.20
60-Month Beta 0.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.